SEMA3G Antikörper (Middle Region)

Produktnummer ABIN954720

Produktdetails anti-SEMA3G Antikörper

Target: SEMA3G (Sema Domain, Immunoglobulin Domain (Ig), Short Basic Domain, Secreted, (Semaphorin) 3G (SEMA3G))

Bindungsspezifität: AA 223-252, Middle Region

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser SEMA3G Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)

Spezifität: Recognizes SEMA3G (Center).

Aufreinigung: Protein A column followed by peptide Affinity purification

Immunogen: KLH conjugated synthetic peptide between 223-252 amino acids from the Central region of Human SEMA3G Genename: SEMA3G

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.25 mg/mL

Buffer: PBS with 0.09 % (W/V) Sodium Azide as preservative

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Referenzen für anti-SEMA3G Antikörper (ABIN954720)

Thal, Züchner, Gierer, Schulte, Schöls, Schüle, Synofzik: "Abnormal Paraplegin Expression in Swollen Neurites, τ- and α-Synuclein Pathology in a Case of Hereditary Spastic Paraplegia SPG7 with an Ala510Val Mutation." in: International journal of molecular sciences, Vol. 16, Issue 10, pp. 25050-66, (2016) (PubMed).

Franke, Rickelt, Zimbelmann, Dörflinger, Kuhn, Frey, Heid, Rosin-Arbesfeld et al.: "Striatins as plaque molecules of zonulae adhaerentes in simple epithelia, of tessellate junctions in stratified epithelia, of cardiac composite junctions and of various size classes of lateral ..." in: Cell and tissue research, Vol. 359, Issue 3, pp. 779-97, (2015) (PubMed).

Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." in: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).

Talmud, Drenos, Shah, Shah, Palmen, Verzilli, Gaunt, Pallas, Lovering, Li, Casas, Sofat, Kumari, Rodriguez, Johnson, Newhouse, Dominiczak, Samani, Caulfield, Sever, Stanton, Shields, Padmanabhan et al.: "Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. ..." in: American journal of human genetics, Vol. 85, Issue 5, pp. 628-42, (2009) (PubMed).

Karayan-Tapon, Wager, Guilhot, Levillain, Marquant, Clarhaut, Potiron, Roche: "Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?" in: British journal of cancer, Vol. 99, Issue 7, pp. 1153-60, (2008) (PubMed).

Kigel, Varshavsky, Kessler, Neufeld: "Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells." in: PLoS ONE, Vol. 3, Issue 9, pp. e3287, (2008) (PubMed).

Rikova, Guo, Zeng, Possemato, Yu, Haack, Nardone, Lee, Reeves, Li, Hu, Tan, Stokes, Sullivan, Mitchell, Wetzel, Macneill, Ren, Yuan, Bakalarski, Villen, Kornhauser, Smith, Li, Zhou, Gygi, Gu et al.: "Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. ..." in: Cell, Vol. 131, Issue 6, pp. 1190-203, (2007) (PubMed).

Howell, Shindo, Murray, Gridley, Wilson, Schimenti: "Mutation of a ubiquitously expressed mouse transmembrane protein (Tapt1) causes specific skeletal homeotic transformations." in: Genetics, Vol. 175, Issue 2, pp. 699-707, (2007) (PubMed).

Fukuda, Mikoshiba: "Tac2-N, an atypical C-type tandem C2 protein localized in the nucleus." in: FEBS letters, Vol. 503, Issue 2-3, pp. 217-8, (2001) (PubMed).

Details zu SEMA3G

Target: SEMA3G (Sema Domain, Immunoglobulin Domain (Ig), Short Basic Domain, Secreted, (Semaphorin) 3G (SEMA3G))

Andere Bezeichnung: SEMA3G (SEMA3G Produkte)

Synonyme: sem2 antikoerper, AK129018 antikoerper, CSG53 antikoerper, RGD1306079 antikoerper, semaphorin 3G antikoerper, sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G antikoerper, SEMA3G antikoerper, Sema3g antikoerper, sema3g antikoerper

Hintergrund: SEMA3G has chemorepulsive activities for sympathetic axons. Ligand of NRP2 (By similarity).Synonyms: Semaphorin sem2, Semaphorin-3G

Gen-ID: 56920

NCBI Accession: NP_064548